Latest filing published 22 Apr 2022 for Kilitch Drugs (India) Limited.
Filing timeline
BuySaleMukund Mehta: trading record in brief
Mukund Mehta is a declared insider of Kilitch Drugs (India) Limited, with filings sourced from SEBI (PIT + SAST). We count 2 filings; the first trade dates from 11 April 2022 and the latest from 22 April 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 22 April 2022 came the latest disclosure, a transaction in Kilitch Drugs (India) Limited. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mukund Mehta
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,111,768 sharesEquity SharesSEBI:6703b2175c031c21f53e908e7d8d64ee8034ff6e
- 1,111,768 sharesEquity SharesSEBI:59d5bb698dfa9c3261b555b8e7b715c8a91af1caCanonical exit: 10 Jul 2022 (T+90)
2 of 2 declarations